Niall Pearson Corporate Broker at Hybridan on Biotech Sector

Niall Pearson a Corporate Broker at Hybridan chats with DirectorsTalk about the Biotech Sector. Niall provides some valuable insight into the Biotech Sector, explains the valuation gap and provides his thoughts on the sector outlook.

 

Niall has an extensive network of small cap investors, covering a range of industries and geographies. Prior to joining the City with another city broker, Niall worked for an investor relations consultancy covering the resources sector where he worked with a number of AIM companies to help raise their profile amongst institutional and private client investors. Niall likes to relax in his native Suffolk either shooting, playing golf or watching rugby.
As AIM brokers and advisers Hybridan are dedicated to fund raising, share price support and providing market-driven corporate finance advice. They raise capital for companies in the most efficient manner possible and communicate the investment cases of their clients to the market through equity research and investor road shows. Hybridan provide market-driven corporate finance advice to clients to help deliver shareholder value.

 

4d pharma plc LON:DDDD is a pharmaceutical company focussing on developing a number of projects targeting important new therapeutic areas. The company combines an understanding of, and access to solutions for, the technical, regulatory, clinical and financial challenges that are required to bring novel therapeutics to market.

Click to view all articles for the EPIC: ,
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    DirectorsTalk

    More articles like this

    4d Pharma Plc

    People with fibromyalgia have different gut bacteria

    A study that compared women with and without fibromyalgia has, for the first time, linked gut bacteria to the long-lasting disease and its main symptoms. Researchers in Canada identified 19 species of gut bacteria that were

    4d Pharma Plc

    Findings link gut bacteria and Fibromyalgia

    Fibromyalgia affects 2-4 percent of the population and has no known cure. Symptoms include fatigue, impaired sleep, and cognitive difficulties, but the disease is most clearly characterized by widespread chronic pain. As reported in the journal Pain,

    4d Pharma Plc

    Gut bacteria: The surprising impact of viruses

    The microbiome plays a vital role in health. A recent study has investigated how viruses that kill gut bacteria influence these microbes. The findings make an already complicated picture much more so. The microbiome is both

    4d Pharma Plc

    4D pharma plc Presents MRx0518 combination study at ASCO

    4D pharma plc (LON: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, today announced the presentation of a poster detailing its Phase I/II clinical study of MRx0518 combined with KEYTRUDA® in patients with solid

    4d Pharma Plc

    4D pharma plc Directors purchase more shares in company

    4D pharma plc (LON: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, has today announced that David Norwood, Duncan Peyton and Alex Stevenson have purchased ordinary shares in the Company as listed below. Following this transaction,

    4d Pharma Plc

    4D pharma plc Presents Phase Ib Clinical Data on Thetanix

    4D pharma plc (LON: DDDD), a pharmaceutical company focusing on the development of Live Biotherapeutics, today announced that data from the completed Phase Ib clinical study of Thetanix® for the treatment of Crohn’s disease will be

    4d Pharma Plc

    Can this food additive turn our gut bacteria against us?

    E171 is a food additive that manufacturers use to whiten various products, including chewing gum, cake icing, and candy, for instance. While the addition of this substance may render certain products more appealing, there is an

    4d Pharma Plc

    7 Things Doctors Want You To Know About IBS

    Irritable bowel syndrome, or IBS, is one of those health conditions that can be difficult to talk about. And when you are struggling with things like diarrhea, constipation, gas, and bloating, it’s completely understandable. But there

    4d Pharma Plc

    4D pharma plc Participation in Microbiome Conference

    4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, today announces its participation in the inaugural Chardan Capital Markets LLC Microbiome Medicines Summit. Alex Stevenson, 4D’s Chief Scientific Officer, gave a